01 7Fycompa
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 252
2019 Revenue in Millions : 225
Growth (%) : 12
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 254
2020 Revenue in Millions : 242
Growth (%) : 13
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 296
2021 Revenue in Millions : 254
Growth (%) : 16
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 178
2022 Revenue in Millions : 296
Growth (%) : -32
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 129
2016 Revenue in Millions : 92
Growth (%) : 40
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 167
2017 Revenue in Millions : 121
Growth (%) : 39%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 220
2018 Revenue in Millions : 173
Growth (%) : 27
LOOKING FOR A SUPPLIER?